Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide
Abstract
:1. Introduction
2. Results and Discussion
3. Materials and Methods
3.1. Ethics Committee Approval
3.2. Animals
3.3. Experimental Design
3.4. Mineralization and Elemental Analysis
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Sample Availability
References
- Nehme, A.; Zouein, F.A.; Zayeri, Z.D.; Zibara, K. An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology. J. Cardiovasc. Dev. Dis. 2019, 6, 14. [Google Scholar] [CrossRef]
- Arendse, L.B.; Danser, A.H.J.; Poglitsch, M.; Touyz, R.M.; Burnett, J.C.; Llorens-Cortes, C.; Ehlers, M.R.; Sturrock, E.D. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. Pharmacol. Rev. 2019, 71, 539–570. [Google Scholar] [CrossRef] [PubMed]
- Antlanger, M.; Bernhofer, S.; Kovarik, J.J.; Kopecky, C.; Kaltenecker, C.C.; Domenig, O.; Poglitsch, M.; Säemann, M.D. Effects of Direct Renin Inhibition Versus Angiotensin II Receptor Blockade on Angiotensin Profiles in Non-Diabetic Chronic Kidney Disease. Ann. Med. 2017, 49, 525–533. [Google Scholar] [CrossRef] [PubMed]
- Cruz-López, E.O.; Ye, D.; Wu, C.; Lu, H.S.; Uijl, E.; Mirabito Colafella, K.M.; Danser, A.H.J. Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease. Hypertension 2022, 79, 2115–2126. [Google Scholar] [CrossRef] [PubMed]
- Kozłowski, H.; Bal, W.; Dyba, M.; Kowalik-Jankowska, T. Specific Structure-Stability Relations in Metallopeptides. Coord. Chem. Rev. 1999, 184, 319–346. [Google Scholar] [CrossRef]
- Frączyk, T. Cu(II)-Binding N-Terminal Sequences of Human Proteins. Chem. Biodivers. 2021, 18, e2100043. [Google Scholar] [CrossRef]
- Yako, N.; Young, T.R.; Cottam Jones, J.M.; Hutton, C.A.; Wedd, A.G.; Xiao, Z. Copper Binding and Redox Chemistry of the Aβ16 Peptide and Its Variants: Insights into Determinants of Copper-Dependent Reactivity. Metallomics 2017, 9, 278–291. [Google Scholar] [CrossRef]
- Xia, N.; Liu, G.; Zhang, S.; Shang, Z.; Yang, Y.; Li, Y.; Liu, L. Oxidase-Mimicking Peptide-Copper Complexes and Their Applications in Sandwich Affinity Biosensors. Anal. Chim. Acta 2022, 1214, 339965. [Google Scholar] [CrossRef]
- Kjaergaard, C.H.; Qayyum, M.F.; Wong, S.D.; Xu, F.; Hemsworth, G.R.; Walton, D.J.; Young, N.A.; Davies, G.J.; Walton, P.H.; Johansen, K.S.; et al. Spectroscopic and Computational Insight into the Activation of O2 by the Mononuclear Cu Center in Polysaccharide Monooxygenases. Proc. Natl. Acad. Sci. USA 2014, 111, 8797–8802. [Google Scholar] [CrossRef]
- Park, G.Y.; Lee, J.Y.; Himes, R.A.; Thomas, G.S.; Blackburn, N.J.; Karlin, K.D. Copper-Peptide Complex Structure and Reactivity When Found in Conserved His-Xaa-His Sequences. J. Am. Chem. Soc. 2014, 136, 12532–12535. [Google Scholar] [CrossRef]
- Brander, S.; Horvath, I.; Ipsen, J.Ø.; Peciulyte, A.; Olsson, L.; Hernández-Rollán, C.; Nørholm, M.H.H.; Mossin, S.; Leggio, L.L.; Probst, C.; et al. Biochemical Evidence of Both Copper Chelation and Oxygenase Activity at the Histidine Brace. Sci. Rep. 2020, 10, 16369. [Google Scholar] [CrossRef] [PubMed]
- Ufnalska, I.; Drew, S.C.; Zhukov, I.; Szutkowski, K.; Wawrzyniak, U.E.; Wróblewski, W.; Frączyk, T.; Bal, W. Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction. Inorg. Chem. 2021, 60, 18048–18057. [Google Scholar] [CrossRef]
- Pereira, T.C.B.; Campos, M.M.; Bogo, M.R. Copper Toxicology, Oxidative Stress and Inflammation Using Zebrafish as Experimental Model. J. Appl. Toxicol. 2016, 36, 876–885. [Google Scholar] [CrossRef] [PubMed]
- Li, Y. Copper Homeostasis: Emerging Target for Cancer Treatment. IUBMB Life 2020, 72, 1900–1908. [Google Scholar] [CrossRef]
- Dorman, D.C.; Mokashi, V.; Wagner, D.J.; Olabisi, A.O.; Wong, B.A.; Moss, O.R.; Centeno, J.A.; Guandalini, G.; Jackson, D.A.; Dennis, W.E.; et al. Biological Responses in Rats Exposed to Cigarette Smoke and Middle East Sand (Dust). Inhal. Toxicol. 2012, 24, 109–124. [Google Scholar] [CrossRef] [PubMed]
- Pinto, E.; Cruz, M.; Ramos, P.; Santos, A.; Almeida, A. Metals Transfer from Tobacco to Cigarette Smoke: Evidences in Smokers’ Lung Tissue. J. Hazard. Mater. 2017, 325, 31–35. [Google Scholar] [CrossRef]
- Afridi, H.I.; Kazi, T.G.; Kazi, N.G.; Jamali, M.K.; Arain, M.B.; Sirajuddin; Baig, J.A.; Kandhro, G.A.; Wadhwa, S.K.; Shah, A.Q.A.; et al. Evaluation of Cadmium, Lead, Nickel and Zinc Status in Biological Samples of Smokers and Nonsmokers Hypertensive Patients. J. Hum. Hypertens. 2010, 24, 34–43. [Google Scholar] [CrossRef] [PubMed]
- Afridi, H.I.; Talpur, F.N.; Kazi, T.G.; Brabazon, D. Assessment of Toxic Elements in the Samples of Different Cigarettes and Their Effect on the Essential Elemental Status in the Biological Samples of Irish Hypertensive Consumers. J. Hum. Hypertens. 2015, 29, 309–315. [Google Scholar] [CrossRef]
- Talhout, R.; Schulz, T.; Florek, E.; van Benthem, J.; Wester, P.; Opperhuizen, A. Hazardous Compounds in Tobacco Smoke. Int. J. Environ. Res. Public Health 2011, 8, 613–628. [Google Scholar] [CrossRef]
- Napierala, M.; Merritt, T.A.; Miechowicz, I.; Mielnik, K.; Mazela, J.; Florek, E. The Effect of Maternal Tobacco Smoking and Second-Hand Tobacco Smoke Exposure on Human Milk Oxidant-Antioxidant Status. Environ. Res. 2019, 170, 110–121. [Google Scholar] [CrossRef]
- Szyfter, K.; Napierala, M.; Florek, E.; Braakhuis, B.J.M.; Takes, R.P.; Rodrigo, J.P.; Rinaldo, A.; Silver, C.E.; Ferlito, A. Molecular and Health Effects in the Upper Respiratory Tract Associated with Tobacco Smoking Other than Cigarettes. Int. J. Cancer 2019, 144, 2635–2643. [Google Scholar] [CrossRef] [PubMed]
- Yaprak, E.; Yolcubal, İ. Presence of Toxic Heavy Metals in Platelet-Rich Fibrin: A Pilot Study. Biol. Trace Elem. Res. 2019, 191, 363–369. [Google Scholar] [CrossRef]
- Zhang, W.Z.; Butler, J.J.; Cloonan, S.M. Smoking-Induced Iron Dysregulation in the Lung. Free Radic. Biol. Med. 2019, 133, 238–247. [Google Scholar] [CrossRef] [PubMed]
- Genchi, G.; Sinicropi, M.S.; Lauria, G.; Carocci, A.; Catalano, A. The Effects of Cadmium Toxicity. Int. J. Environ. Res. Public Health 2020, 17, 3782. [Google Scholar] [CrossRef] [PubMed]
- Morton, J.; Tan, E.; Suvarna, S.K. Multi-Elemental Analysis of Human Lung Samples Using Inductively Coupled Plasma Mass Spectrometry. J. Trace Elem. Med. Biol. 2017, 43, 63–71. [Google Scholar] [CrossRef]
- Szentmihályi, K.; Blázovics, A.; May, Z.; Mohai, M.; Süle, K.; Albert, M.; Szénási, G.; Sebestény, A.; Máthé, C. Metal Element Alteration in the Lung by Cisplatin and CV247 Administration. Biomed. Pharmacother. 2020, 128, 110307. [Google Scholar] [CrossRef]
- Fresquez, M.R.; Pappas, R.S.; Watson, C.H. Establishment of Toxic Metal Reference Range in Tobacco from US Cigarettes. J. Anal. Toxicol. 2013, 37, 298–304. [Google Scholar] [CrossRef]
- Pappas, R.S.; Fresquez, M.R.; Martone, N.; Watson, C.H. Toxic Metal Concentrations in Mainstream Smoke from Cigarettes Available in the USA. J. Anal. Toxicol. 2014, 38, 204–211. [Google Scholar] [CrossRef]
- Zumbado, M.; Luzardo, O.P.; Rodríguez-Hernández, Á.; Boada, L.D.; Henríquez-Hernández, L.A. Differential Exposure to 33 Toxic Elements through Cigarette Smoking, Based on the Type of Tobacco and Rolling Paper Used. Environ. Res. 2019, 169, 368–376. [Google Scholar] [CrossRef]
- Galażyn-Sidorczuk, M.; Brzóska, M.M.; Moniuszko-Jakoniuk, J. Estimation of Polish Cigarettes Contamination with Cadmium and Lead, and Exposure to These Metals via Smoking. Environ. Monit. Assess. 2008, 137, 481–493. [Google Scholar] [CrossRef]
- Tang, L.; Qiu, R.; Tang, Y.; Wang, S. Cadmium-Zinc Exchange and Their Binary Relationship in the Structure of Zn-Related Proteins: A Mini Review. Metallomics 2014, 6, 1313–1323. [Google Scholar] [CrossRef]
- Padjasek, M.; Kocyła, A.; Kluska, K.; Kerber, O.; Tran, J.B.; Krężel, A. Structural Zinc Binding Sites Shaped for Greater Works: Structure-Function Relations in Classical Zinc Finger, Hook and Clasp Domains. J. Inorg. Biochem. 2020, 204, 110955. [Google Scholar] [CrossRef]
- Krężel, A.; Maret, W. The Bioinorganic Chemistry of Mammalian Metallothioneins. Chem. Rev. 2021, 121, 14594–14648. [Google Scholar] [CrossRef] [PubMed]
- Zwolak, I. The Role of Selenium in Arsenic and Cadmium Toxicity: An Updated Review of Scientific Literature. Biol. Trace Elem. Res. 2020, 193, 44–63. [Google Scholar] [CrossRef]
- Cui, Z.-G.; Ahmed, K.; Zaidi, S.F.; Muhammad, J.S. Ins and Outs of Cadmium-Induced Carcinogenesis: Mechanism and Prevention. Cancer Treat. Res. Commun. 2021, 27, 100372. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.S.; Kim, Y.J.; Seo, Y.R. An Overview of Carcinogenic Heavy Metal: Molecular Toxicity Mechanism and Prevention. J. Cancer Prev. 2015, 20, 232–240. [Google Scholar] [CrossRef]
- Ebrahimi, M.; Khalili, N.; Razi, S.; Keshavarz-Fathi, M.; Khalili, N.; Rezaei, N. Effects of Lead and Cadmium on the Immune System and Cancer Progression. J. Environ. Health Sci. Eng. 2020, 18, 335–343. [Google Scholar] [CrossRef]
- Pappas, R.S. Toxic Elements in Tobacco and in Cigarette Smoke: Inflammation and Sensitization. Metallomics 2011, 3, 1181–1198. [Google Scholar] [CrossRef] [PubMed]
- Massadeh, A.; Gharibeh, A.; Omari, K.; Al-Momani, I.; Alomari, A.; Tumah, H.; Hayajneh, W. Simultaneous Determination of Cd, Pb, Cu, Zn, and Se in Human Blood of Jordanian Smokers by ICP-OES. Biol. Trace Elem. Res. 2010, 133, 1–11. [Google Scholar] [CrossRef]
- Badea, M.; Luzardo, O.P.; González-Antuña, A.; Zumbado, M.; Rogozea, L.; Floroian, L.; Alexandrescu, D.; Moga, M.; Gaman, L.; Radoi, M.; et al. Body Burden of Toxic Metals and Rare Earth Elements in Non-Smokers, Cigarette Smokers and Electronic Cigarette Users. Environ. Res. 2018, 166, 269–275. [Google Scholar] [CrossRef]
- Meral, I.; Akdemir, F.N.E. Serum Mineral Status of Long-Term Cigarette Smokers. Toxicol. Ind. Health 2015, 31, 92–96. [Google Scholar] [CrossRef]
- Zabłocka-Słowińska, K.; Płaczkowska, S.; Prescha, A.; Pawełczyk, K.; Porębska, I.; Kosacka, M.; Pawlik-Sobecka, L.; Grajeta, H. Serum and Whole Blood Zn, Cu and Mn Profiles and Their Relation to Redox Status in Lung Cancer Patients. J. Trace Elem. Med. Biol. 2018, 45, 78–84. [Google Scholar] [CrossRef] [PubMed]
- Cao, K.; Zhang, J.; Wang, G.; Lin, X.; Zhan, F.; Wu, K.; Tan, W.; Geng, H.; Liu, C. Associations of Trace Element Levels in Paired Serum, Whole Blood, and Tissue: An Example of Esophageal Squamous Cell Carcinoma. Environ. Sci. Pollut. Res. 2022. [Google Scholar] [CrossRef]
- Ge, E.J.; Bush, A.I.; Casini, A.; Cobine, P.A.; Cross, J.R.; DeNicola, G.M.; Dou, Q.P.; Franz, K.J.; Gohil, V.M.; Gupta, S.; et al. Connecting Copper and Cancer: From Transition Metal Signalling to Metalloplasia. Nat. Rev. Cancer 2022, 22, 102–113. [Google Scholar] [CrossRef] [PubMed]
- Ramchandani, D.; Berisa, M.; Tavarez, D.A.; Li, Z.; Miele, M.; Bai, Y.; Lee, S.B.; Ban, Y.; Dephoure, N.; Hendrickson, R.C.; et al. Copper Depletion Modulates Mitochondrial Oxidative Phosphorylation to Impair Triple Negative Breast Cancer Metastasis. Nat. Commun. 2021, 12, 7311. [Google Scholar] [CrossRef]
- Salnikow, K. Role of Iron in Cancer. Semin. Cancer Biol. 2021, 76, 189–194. [Google Scholar] [CrossRef] [PubMed]
- Liu, S.; Cao, X.; Wang, D.; Zhu, H. Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology. Arch. Biochem. Biophys. 2022, 723, 109199. [Google Scholar] [CrossRef]
- Kuang, Y.; Wang, Q. Iron and Lung Cancer. Cancer Lett. 2019, 464, 56–61. [Google Scholar] [CrossRef]
- Siragy, H. A Current Evaluation of the Safety of Angiotensin Receptor Blockers and Direct Renin Inhibitors. Vasc. Health Risk Manag. 2011, 7, 297–313. [Google Scholar] [CrossRef]
- Zhang, J.; Liu, J.; Chen, J.; Li, X.; Wu, Y.; Chen, H.; Wu, W.; Zhang, K.; Gu, L. Angiotensin Receptor Blockers (ARBs) Reduce the Risk of Lung Cancer: A Systematic Review and Meta-Analysis. Int. J. Clin. Exp. Med. 2015, 8, 12656–12660. [Google Scholar]
- Ishikane, S.; Takahashi-Yanaga, F. The Role of Angiotensin II in Cancer Metastasis: Potential of Renin-Angiotensin System Blockade as a Treatment for Cancer Metastasis. Biochem. Pharmacol. 2018, 151, 96–103. [Google Scholar] [CrossRef] [PubMed]
- Datzmann, T.; Fuchs, S.; Andree, D.; Hohenstein, B.; Schmitt, J.; Schindler, C. Systematic Review and Meta-Analysis of Randomised Controlled Clinical Trial Evidence Refutes Relationship between Pharmacotherapy with Angiotensin-Receptor Blockers and an Increased Risk of Cancer. Eur. J. Intern. Med. 2019, 64, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Rachow, T.; Schiffl, H.; Lang, S.M. Risk of Lung Cancer and Renin-Angiotensin Blockade: A Concise Review. J. Cancer Res. Clin. Oncol. 2021, 147, 195–204. [Google Scholar] [CrossRef]
- Sanidas, E.; Velliou, M.; Papadopoulos, D.; Fotsali, A.; Iliopoulos, D.; Mantzourani, M.; Toutouzas, K.; Barbetseas, J. Antihypertensive Drugs and Risk of Cancer: Between Scylla and Charybdis. Am. J. Hypertens. 2020, 33, 1049–1058. [Google Scholar] [CrossRef]
- Berrido, A.M.; Byrd, J.B. Angiotensin Receptor Blockers and the Risk of Cancer: Insights from Clinical Trials and Recent Drug Recalls. Curr. Hypertens. Rep. 2020, 22, 20. [Google Scholar] [CrossRef]
- Byrd, J.B.; Chertow, G.M.; Bhalla, V. Hypertension Hot Potato—Anatomy of the Angiotensin-Receptor Blocker Recalls. N. Engl. J. Med. 2019, 380, 1589–1591. [Google Scholar] [CrossRef] [PubMed]
- Garner, R.E.; Levallois, P. Associations between Cadmium Levels in Blood and Urine, Blood Pressure and Hypertension among Canadian Adults. Environ. Res. 2017, 155, 64–72. [Google Scholar] [CrossRef]
- Martins, A.C.; Almeida Lopes, A.C.B.; Urbano, M.R.; Carvalho, M.F.H.; Silva, A.M.R.; Tinkov, A.A.; Aschner, M.; Mesas, A.E.; Silbergeld, E.K.; Paoliello, M.M.B. An Updated Systematic Review on the Association between Cd Exposure, Blood Pressure and Hypertension. Ecotoxicol. Environ. Saf. 2021, 208, 111636. [Google Scholar] [CrossRef]
- Rana, M.N.; Tangpong, J.; Rahman, M.M. Toxicodynamics of Lead, Cadmium, Mercury and Arsenic-Induced Kidney Toxicity and Treatment Strategy: A Mini Review. Toxicol. Rep. 2018, 5, 704–713. [Google Scholar] [CrossRef]
- da Cunha Martins, A.; Carneiro, M.F.H.; Grotto, D.; Adeyemi, J.A.; Barbosa, F. Arsenic, Cadmium, and Mercury-Induced Hypertension: Mechanisms and Epidemiological Findings. J. Toxicol. Environ. Health Part B 2018, 21, 61–82. [Google Scholar] [CrossRef]
- Almeer, R.S.; AlBasher, G.I.; Alarifi, S.; Alkahtani, S.; Ali, D.; Abdel Moneim, A.E. Royal Jelly Attenuates Cadmium-Induced Nephrotoxicity in Male Mice. Sci. Rep. 2019, 9, 5825. [Google Scholar] [CrossRef]
- Peana, M.; Pelucelli, A.; Chasapis, C.T.; Perlepes, S.P.; Bekiari, V.; Medici, S.; Zoroddu, M.A. Biological Effects of Human Exposure to Environmental Cadmium. Biomolecules 2022, 13, 36. [Google Scholar] [CrossRef]
- Angeli, J.K.; Cruz Pereira, C.A.; de Oliveira Faria, T.; Stefanon, I.; Padilha, A.S.; Vassallo, D.V. Cadmium Exposure Induces Vascular Injury Due to Endothelial Oxidative Stress: The Role of Local Angiotensin II and COX-2. Free Radic. Biol. Med. 2013, 65, 838–848. [Google Scholar] [CrossRef]
- Marcum, Z.; Cohen, J.; Larson, E.; Williamson, J.; Bress, A. Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity? NAM Perspect. 2022, 324, 1825–1826. [Google Scholar] [CrossRef] [PubMed]
- Chen, C.; Xun, P.; Nishijo, M.; He, K. Cadmium Exposure and Risk of Lung Cancer: A Meta-Analysis of Cohort and Case—Control Studies among General and Occupational Populations. J. Expo. Sci. Environ. Epidemiol. 2016, 26, 437–444. [Google Scholar] [CrossRef] [PubMed]
- Hartwig, A. Cadmium and Cancer. In Cadmium: From Toxicity to Essentiality. Metal Ions in Life Sciences; Sigel, A., Sigel, H., Sigel, R., Eds.; Springer: Dordrecht, The Netherlands, 2013; Volume 11, pp. 491–507. [Google Scholar]
- Manz, D.H.; Blanchette, N.L.; Paul, B.T.; Torti, F.M.; Torti, S.V. Iron and Cancer: Recent Insights. Ann. N. Y. Acad. Sci. 2016, 1368, 149–161. [Google Scholar] [CrossRef]
- Opelz, G.; Döhler, B. Treatment of Kidney Transplant Recipients with ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report. Am. J. Transplant. 2011, 11, 2483–2489. [Google Scholar] [CrossRef]
- Jiang, H.; Tai, Z.; Chen, Z.; Zhu, Q.; Bao, L. Clinical Applicability of Renin-Angiotensin System Inhibitors in Cancer Treatment. Am. J. Cancer Res. 2021, 11, 318–336. [Google Scholar]
- Yang, J.; Yang, X.; Gao, L.; Zhang, J.; Yi, C.; Huang, Y. The Role of the Renin-Angiotensin System Inhibitors in Malignancy: A Review. Am. J. Cancer Res. 2021, 11, 884–897. [Google Scholar]
- de Miranda, F.S.; Guimarães, J.P.T.; Menikdiwela, K.R.; Mabry, B.; Dhakal, R.; Rahman, R.l.; Moussa, H.; Moustaid-Moussa, N. Breast Cancer and the Renin-Angiotensin System (RAS): Therapeutic Approaches and Related Metabolic Diseases. Mol. Cell. Endocrinol. 2021, 528, 111245. [Google Scholar] [CrossRef]
- Khoshghamat, N.; Jafari, N.; Toloue-pouya, V.; Azami, S.; Mirnourbakhsh, S.H.; Khazaei, M.; Ferns, G.A.; Rajabian, M.; Avan, A. The Therapeutic Potential of Renin-Angiotensin System Inhibitors in the Treatment of Pancreatic Cancer. Life Sci. 2021, 270, 119118. [Google Scholar] [CrossRef] [PubMed]
- Labandeira-Garcia, J.L.; Labandeira, C.M.; Valenzuela, R.; Pedrosa, M.A.; Quijano, A.; Rodriguez-Perez, A.I. Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment. Biomedicines 2022, 10, 502. [Google Scholar] [CrossRef] [PubMed]
- Tulbă, D.; Avasilichioaiei, M.; Dima, N.; Crăciun, L.; Bălănescu, P.; Buzea, A.; Băicuș, C.; Popescu, B.O. Shared Molecular Targets in Parkinson’s Disease and Arterial Hypertension: A Systematic Review. Biomedicines 2022, 10, 653. [Google Scholar] [CrossRef] [PubMed]
- Gouveia, F.; Camins, A.; Ettcheto, M.; Bicker, J.; Falcão, A.; Cruz, M.T.; Fortuna, A. Targeting Brain Renin-Angiotensin System for the Prevention and Treatment of Alzheimer’s Disease: Past, Present and Future. Ageing Res. Rev. 2022, 77, 101612. [Google Scholar] [CrossRef]
- National Research Council. Nutrient Requirements of Laboratory Animals, 4th ed.; National Academies Press: Washington, DC, USA, 1995; ISBN 978-0-309-05126-2.
- Hongo, M.; Ishizaka, N.; Furuta, K.; Yahagi, N.; Saito, K.; Sakurai, R.; Matsuzaki, G.; Koike, K.; Nagai, R. Administration of Angiotensin II, but Not Catecholamines, Induces Accumulation of Lipids in the Rat Heart. Eur. J. Pharmacol. 2009, 604, 87–92. [Google Scholar] [CrossRef]
- Patil, P.D.; Melo, A.C.; Westwood, B.M.; Tallant, E.A.; Gallagher, P.E. A Polyphenol-Rich Extract from Muscadine Grapes Prevents Hypertension-Induced Diastolic Dysfunction and Oxidative Stress. Antioxidants 2022, 11, 2026. [Google Scholar] [CrossRef]
- Satou, R.; Franco, M.; Dugas, C.M.; Katsurada, A.; Navar, L.G. Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension. Int. J. Mol. Sci. 2022, 23, 7680. [Google Scholar] [CrossRef]
- Zhang, Y.; Lin, X.; Chu, Y.; Chen, X.; Du, H.; Zhang, H.; Xu, C.; Xie, H.; Ruan, Q.; Lin, J.; et al. Dapagliflozin: A Sodium-Glucose Cotransporter 2 Inhibitor, Attenuates Angiotensin II-Induced Cardiac Fibrotic Remodeling by Regulating TGFβ1/Smad Signaling. Cardiovasc. Diabetol. 2021, 20, 121. [Google Scholar] [CrossRef]
- Castoldi, G.; Carletti, R.; Ippolito, S.; Villa, I.; Palmisano, B.; Bolamperti, S.; Rubinacci, A.; Zerbini, G.; Meani, M.; Zatti, G.; et al. Angiotensin II Modulates Calcium/Phosphate Excretion in Experimental Model of Hypertension: Focus on Bone. Biomedicines 2022, 10, 2928. [Google Scholar] [CrossRef]
- Donertaz Ayaz, B.; Oliveira, A.C.; Malphurs, W.L.; Redler, T.; de Araujo, A.M.; Sharma, R.K.; Sirmagul, B.; Zubcevic, J. Central Administration of Hydrogen Sulfide Donor NaHS Reduces Iba1-Positive Cells in the PVN and Attenuates Rodent Angiotensin II Hypertension. Front. Neurosci. 2021, 15, 690919. [Google Scholar] [CrossRef]
- Castoldi, G.; Carletti, R.; Ippolito, S.; Stella, A.; Zerbini, G.; Pelucchi, S.; Zatti, G.; di Gioia, C.R.T. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension. Int. J. Mol. Sci. 2021, 22, 13678. [Google Scholar] [CrossRef]
- Song, J.; Zhang, Z.; Dong, Z.; Liu, X.; Liu, Y.; Li, X.; Xu, Y.; Guo, Y.; Wang, N.; Zhang, M.; et al. MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling. J. Cardiovasc. Transl. Res. 2022, 15, 535–547. [Google Scholar] [CrossRef]
- Valle Martins, A.L.; da Silva, F.A.; Bolais-Ramos, L.; de Oliveira, G.C.; Ribeiro, R.C.; Pereira, D.A.A.; Annoni, F.; Diniz, M.M.L.; Silva, T.G.F.; Zivianni, B.; et al. Increased Circulating Levels of Angiotensin-(1–7) in Severely Ill COVID-19 Patients. ERJ Open Res. 2021, 7, 00114–02021. [Google Scholar] [CrossRef] [PubMed]
- Schalekamp, M.A.D.H.; Danser, A.H.J. Angiotensin II Production and Distribution in the Kidney: I. A Kinetic Model. Kidney Int. 2006, 69, 1543–1552. [Google Scholar] [CrossRef] [PubMed]
- van Kats, J.P.; de Lannoy, L.M.; Danser, A.H.J.; van Meegen, J.R.; Verdouw, P.D.; Schalekamp, M.A.D.H. Angiotensin II Type 1 (AT1) Receptor-Mediated Accumulation of Angiotensin II in Tissues and Its Intracellular Half-Life In Vivo. Hypertension 1997, 30, 42–49. [Google Scholar] [CrossRef]
- Reinoso, R.F.; Telfer, B.A.; Rowland, M. Tissue Water Content in Rats Measured by Desiccation. J. Pharmacol. Toxicol. Methods 1997, 38, 87–92. [Google Scholar] [CrossRef]
- Napierala, M.; Merritt, T.; Mazela, J.; Jablecka, K.; Miechowicz, I.; Marszalek, A.; Florek, E. The Effect of Tobacco Smoke on Oxytocin Concentrations and Selected Oxidative Stress Parameters in Plasma during Pregnancy and Post-Partum—An Experimental Model. Hum. Exp. Toxicol. 2017, 36, 135–145. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Szukalska, M.; Frączyk, T.; Florek, E.; Pączek, L. Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide. Molecules 2023, 28, 628. https://doi.org/10.3390/molecules28020628
Szukalska M, Frączyk T, Florek E, Pączek L. Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide. Molecules. 2023; 28(2):628. https://doi.org/10.3390/molecules28020628
Chicago/Turabian StyleSzukalska, Marta, Tomasz Frączyk, Ewa Florek, and Leszek Pączek. 2023. "Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide" Molecules 28, no. 2: 628. https://doi.org/10.3390/molecules28020628